Company Filing History:
1 out of 225 
1 out of 492 
Years Active: 2018
Title: Tom Vandenberghe: Innovator in Septic Shock Treatment
Introduction
Tom Vandenberghe is a notable inventor based in Haasdonk, Belgium. He has made significant contributions to the field of medical research, particularly in the treatment of septic shock. His innovative approach focuses on the inactivation of interleukin-1 and interleukin-18 signaling, which are critical in managing inflammation and septic shock.
Latest Patents
Tom Vandenberghe holds a patent for his invention titled "Targeting of interleukin-1 and -18 signaling in treatment of septic shock." This patent describes a method that involves the sequential or simultaneous application of both an interleukin-1 receptor antagonist and an interleukin-18 antibody. In one preferred embodiment, a combination treatment of an IL-1 receptor antagonist and an IL-18 antibody is utilized. This innovative approach aims to improve patient outcomes in cases of severe inflammation and septic shock.
Career Highlights
Throughout his career, Tom Vandenberghe has worked with various organizations, including Vib Vzw and Universiteit Gent. His work has been instrumental in advancing the understanding and treatment of inflammatory conditions. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Tom has collaborated with notable colleagues such as Peter Vandenabeele and Anje Cauwels. These partnerships have contributed to the development of his groundbreaking research and inventions.
Conclusion
Tom Vandenberghe's contributions to the treatment of septic shock through innovative patenting and collaboration highlight his importance in the medical research community. His work continues to pave the way for advancements in the treatment of severe inflammatory conditions.